Bedel Financial Consulting, Inc. Novartis Ag Transaction History
Bedel Financial Consulting, Inc.
- $737 Million
- Q2 2025
A detailed history of Bedel Financial Consulting, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 4,445 shares of NVS stock, worth $581,272. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,445
Previous 4,445
-0.0%
Holding current value
$581,272
Previous $495,000
8.48%
% of portfolio
0.07%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,561Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.36 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.18 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$989 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$931 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $281B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...